共查询到20条相似文献,搜索用时 140 毫秒
1.
2.
以N-羟基-4-甲氧基苯甲醛肟氯化物为原料,经两步反应制得3-对甲氧基苯基-5-甲基-异噁唑-4-甲酰肼(3);3依次经缩合和环合反应合成了一系列新型的2-芳基3-乙酰基-5-(3-对甲氧基苯基-5-甲基-异噁唑-4-基)-Δ4-1,3,4-噁二唑啉衍生物,其结构经~1H NMR,13C NMR,IR,MS(EI)和元素分析表征。 相似文献
3.
4.
以6-氯-3-吡啶甲醛为原料, 通过多步反应合成了一系列3-(吗啉吡啶基)-5-取代异噁唑类化合物, 并用IR, 1H NMR, 13C NMR和MS进行了结构确证. 这些化合物均以异噁唑为母核, 具有近似的平面结构, 在异噁唑环的3-位引入吗啉吡啶基, 而在5-位引入酯基、取代氨基、三唑环和噁唑烷酮环. 研究了这些化合物对金黄色葡萄球菌、耐甲氧西林金黄色葡萄球菌、表皮葡萄球菌、粪肠球菌和大肠杆菌的抑制活性, 发现与噁唑烷酮类上市药物利奈唑胺相比, 目标化合物均显示出更低的抗菌活性, 最低抑制浓度(MIC)大于32 mg/L, 这些试验结果表明异噁唑母核的5-位缺乏sp3杂化结构, 可能会导致抗菌活性的显著降低. 相似文献
5.
以3,5-二取代异噁唑-4-甲酰肼为基本原料制备关键中间体1-(3-对甲氧基苯基-5-甲基异噁唑-4-基)-4-芳基氨基硫脲(3a~3c);3在不同条件下经关环反应制得含有3,5-二取代异噁唑的2-芳氨基噻二唑(4a~4c),2-芳氨基噁二唑(5a~5c)和3-[3′-(4"-甲氧基苯基)-5′-甲基-异噁唑4′-基)-4-芳基-1,2,4-三唑-5-硫酮(6a~6c);6与碘甲(乙)烷反应合成了4-芳基-5-[3′-(4″-甲氧基苯基)-5′-甲基异噁唑-4′-基]-3-甲(乙)硫基-1,2,4-三唑(7a~8c),其结构经1H NMR,IR,MS和元素分析表征,其中4,5,7和8未见文献报道. 相似文献
6.
以3,5-二取代异噁唑-4-甲酰肼为基本原料制备关键中间体1-(3-对甲氧基苯基-5-甲基异噁唑-4-基)-4-芳基氨基硫脲(3a~3c);3在不同条件下经关环反应制得含有3,5-二取代异噁唑的2-芳氨基噻二唑(4a~4c),2-芳氨基噁二唑(5a~5c)和3-[3’-(4″-甲氧基苯基)-5’-甲基-异噁唑-4’-基)-4-芳基-1,2,4-三唑-5-硫酮(6a~6c);6与碘甲(乙)烷反应合成了4-芳基-5-[3’-(4″-甲氧基苯基)-5’-甲基异噁唑-4’-基]-3-甲(乙)硫基-1,2,4-三唑(7a~8c),其结构经1H NMR,IR,MS和元素分析表征,其中4,5,7和8未见文献报道。 相似文献
7.
8.
9.
通过3-乙酰基-5-羟甲基异噁唑衍生的Schiff碱2与由醛肟原位生成的腈氧化物的1,3-偶极环加成反应, “一锅法”制备了5-甲基-5-[5-(叔丁基二甲基硅氧基甲基)-3-异噁唑基]-3-芳基-4-(4-甲氧基苯基)-4,5二氢-1,2,4-噁二唑类化合物4a~4e; 同时由3-乙酰基-5-羟甲基异噁唑衍生的α,β-不饱和酮(5)与取代苯肼的环化反应制备了5-(叔丁基二甲基硅氧基甲基)-3-[(1,5-二芳基)-3-(4,5-二氢吡唑基)]-异噁唑类化合物6a~6i. 所有新化合物的结构经核磁共振谱氢谱和碳谱、质谱、红外光谱以及高分辨质谱等进行了确证. 相似文献
10.
为了寻找新型高效的抗菌先导化合物,采用活性亚结构拼接法,设计合成了17个含哌啶的新型1,2,4-噁二唑类衍生物4a~4b和6a~6o,其结构经1H NMR、13C NMR和高分辨质谱(HRMS)表征. N-(1-苯甲酰基哌啶-4-基)-4-(5-(三氟甲基)-1,2,4-噁二唑-3-基)苯甲酰胺(6e)结构由X射线单晶衍射法加以确证.抗菌活性测试结果表明:在浓度为3.13mg/L时, N-(1-乙酰基哌啶-4-基)-4-(5-(三氟甲基)-1,2,4-噁二唑-3-基)苯甲酰胺(6a)、N-(1-(环丙甲酰基)哌啶-4-基)-4-(5-(三氟甲基)-1,2,4-噁二唑-3-基)苯甲酰胺(6c)、6e、4-((4-(5-(三氟甲基)-1,2,4-噁二唑-3-基)苯甲酰胺基)甲基)哌啶-1-甲酸叔丁酯(4b)和N-((1-(苯甲酰基)哌啶-4-基)甲基-4-(5-(三氟甲基)-1,2,4-噁二唑-3-基)苯甲酰胺(6o)对大豆锈病(Phakopsora pachyrhiz)的抑制率分别为70%、82%、95%、78%和98%,优于Flufenoxa... 相似文献
11.
Russian Journal of General Chemistry - A series of new 2-{3-{4-[(5-aryl-1,2,4-oxadiazol-3-yl)methoxy]phenyl}isoxazol-5-yl}-N-(3,4,5-tri-methylphenyl)thiazol-4-amine derivatives is synthesized, and... 相似文献
12.
Nikolay A. Bumagin Alexey V. Kletskov Sergey K. Petkevich Iryna A. Kolesnik Alexander S. Lyakhov Ludmila S. Ivashkevich Alexander V. Baranovsky Peter V. Kurman Vladimir I. Potkin 《Tetrahedron》2018,74(27):3578-3588
New substituted 3-((1H-1,2,3-triazol-1-yl)methyl)-5-arylisoxazoles (aryl?=?Ph, p-Tol) and 2-(5-phenylisoxazol-3-yl)-5-(2-(1-((5-(p-tolyl)isoxazol-3-yl)methyl)-1H-1,2,3-triazol-4-yl)ethyl)-1,3,4-oxadiazole were synthesized by means of click-chemistry procedures. The obtained compounds were used as ligands in preparation of palladium(II) complexes, and the latter proved to be high-turnover-number catalysts for CC cross-coupling reactions under Green Chemistry conditions. One of the ligands was structurally characterized by single crystal X-ray diffraction, and the structure of complexes was determined by 1H, 13C, 15N NMR spectroscopy and quantum-chemical modeling. 相似文献
13.
Feng Liu Meiyan Wang Xinhuan Teng Peizhi Zhang Lin Jiang 《Research on Chemical Intermediates》2014,40(4):1575-1581
A series of 2-(5-methyl-3-(4-chloro/trifluoromethylphenyl)isoxazol-4-yl)-5-arylamino-1,3,4-oxadiazoles were synthesized from 4-chloro/trifluoromethyl benzaldehyde, ethyl acetoacetate, hydroxylamine hydrochloride, hydrazine hydrate, and aryl isocyanate by multi-step reactions. The structures of the target compounds were elucidated by IR, 1H NMR, MS, and elemental analysis. All these compounds were tested for in vitro antifungal activities against Botrytis cinerea and Rhizoctonia cerealis by the mycelium growth rate method, and the results indicated that some compounds displayed high antifungal activity against Botrytis cinerea. 相似文献
14.
2,2-二甲基-5-取代苯基-3-(1,2,4-三唑-1/4-甲基)-3-戊醇类化合物的合成、表征及生物活性 总被引:1,自引:0,他引:1
取代苯甲醛经缩合、催化氢化、环氧化和开环反应合成了9种2,2-二甲基-5-取代苯基-3-(1,2,4-三唑-1-基甲基)-3-戊醇类化合物和2种2,2-二甲基-5-取代苯基-3-(1,2,4-三唑-4-基甲基)-3-戊醇类新化合物. 并对1,2,4-三唑-1-基衍生物和1,2,4-三唑-4-基衍生物的选择性合成进行了研究; 新化合物结构经质谱, 1H NMR, 元素分析等确证, 并用单晶X射线衍射测定了化合物1a的晶体结构. 生物活性测试结果表明, 部分化合物具有强杀菌活性. 相似文献
15.
3-Amino-2-(isoxazol-3-yl)-4-methoxymethyl-6-methylthieno[2,3-b]pyridine was synthesized by the reaction of 2(1H)-thioxopyridine-3-carbonitrile with 3-chloromethylisoxazole in the presence of two equivalents of KOH. Boiling of 3-amino-2-(isoxazol-3-yl)-4-methoxymethyl-6-meth-ylthieno[2,3-b]pyridine with Raney nickel results in 4-aminothieno[2,3-b;4,5-b′]dipyridine or 5-(4-amino-2-pyridyl)pyridine depending on the reaction conditions.
Published in Russian in Izvestiya Akademii Nauk. Seriya Khimicheskaya, No. 3, pp. 669–670, March, 2008. 相似文献
16.
L. M. Gornostaev G. I. Zolotareva D. Sh. Verkhovodova 《Chemistry of Heterocyclic Compounds》1981,17(9):879-882
In the reaction of 5-chloroanthra[1,9-cd]-6-isoxazolone with pyridine bases the chlorine atom is substituted to give the corresponding pyridinium salts. The pyridine ring of the synthesized anthra[1,9-cd]isoxazol-6-one-5-pyridinium chloride was cleaved by the Zincke method. The reduction of the cleavage product, viz., N-(anthra[1,9-cd]isoxazol-6-on-5-yl)-5-amino-2,4-pentadienal, under various conditions was investigated.Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 9, pp. 1186–1188, September, 1981. 相似文献
17.
为了寻找生物活性良好的噻唑基丙烯腈类化合物, 利用2-[4-(2,6-二氟苯基)噻唑-2-基]乙腈(3)分别与取代氯甲酸酯4和取代苯基异氰酸酯6在碱存在下反应, 合成了8个2-[4-(2,6-二氟苯基)噻唑-2-基]-3-羟基-3-烃氧基丙烯腈化合物5和7个2-[4-(2,6-二氟苯基)噻唑-2-基]-3-羟基-3-取代苯胺基丙烯腈化合物7, 均为首次报道的丙烯腈类化合物. 化合物结构经1H NMR, IR, MS和元素分析表征. 初步生物活性测定结果表明, 在试验浓度下, 目标化合物均具有一定的杀虫和抑菌活性, 其中化合物5f和5h在100 mg/L浓度下对炭疽病菌的抑制率达95%; 化合物5g和7d在250 mg/L浓度下对棉红蜘蛛的致死率达85%. 相似文献
18.
《Mendeleev Communications》2022,32(5):591-593
Water-dispersible complexes of 4-methyl-N-[5-methyl-3-(3,4,5-trimethoxyphenyl)isoxazol-4-yl]benzamide possessing anticancer activity were prepared by its immobilization with biocompatible polymer nanocontainers based on sodium alginate cross-linked with Ca2+ and Mg2+ ions. It was found that this isoxazole derivative retains its structure during immobilization. Colloidal stable nanocontainers filled with this compound exhibit toxicity toward the colon carcinoma (HCT116) tumor cell line. 相似文献
19.
10种未见文献报道的N-[3-(3,4-二甲基-2-吡咯基)-5-巯基-4-均三唑基]-取代芳(氧)酰胺类连杂环化合物通过将5-取代苯基-2-呋喃甲酸及取代苯氧乙酸经酰化后, 分别与3-(3,4-二甲基-2-吡咯基)-4-氨基-5-巯基-1,2,4-三唑在乙腈中反应而合成制得. 结构经元素分析、IR和1H NMR得到确证. 生物活性测试结果表明: 大部分目标化合物具有一定的除草活性. 相似文献
20.
以腺苷为母体,对其N6-位进行结构改造,首先经邻位双羟基保护,N6-位氯代,再在N6-位引入哌嗪环制得中间体2',3'-异丙叉-6-哌嗪嘌呤核苷(4);4与N-氯乙酰苯胺类似物(6a~6h)偶联后脱除邻位双羟基保护合成了8个新型的N6-哌嗪取代腺苷衍生物(8a~8h),其结构经1H NMR,13C NMR和HR-ESI-MS表征。采用MTT法研究了8a~8h对Hela肿瘤细胞的抑制活性。结果表明:大部分目标化合物对Hela肿瘤细胞具有较好的抑制活性,其中2-{4-[9-(3,4-二羟基-5-羟甲基-四氢呋喃-2-基)-9H-嘌呤-6-基]-哌嗪-1-基}-N-(3-氟苯基)-乙酰胺(8e)的活性最好,IC50为21.74μmol·L-1。 相似文献